Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Today symbols : SNYNF save search
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Published: 2024-04-23 (Crawled : 05:00) - globenewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
study
Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 22:00) - prnewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $136.2 -4.19% 1.7K
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.59 2.11% -0.36% 3.8M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
| Email alert
Add to watchlist
RBGPF | News | $51.75 6.46% 3.6K
|
Consumer Non-Durables
| Email alert
Add to watchlist
RBGLY | News | $10.35 -2.05% 500K
|
Manufacturing
| Email alert
Add to watchlist
drug astrazeneca set key therapeutics market
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-22 (Crawled : 22:00) - globenewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
REGN | News | $899.71 0.32% 0.32% 340K
|
Health Technology
| Email alert
Add to watchlist
genetic cell research therapy
Biopharma Layoff Tracker 2024: Pfizer, Sanofi, Vedanta and More Cut Staff
Published: 2024-04-22 (Crawled : 16:00) - biospace.com/
AMRN | News | $0.8648 0.64% 0.64% 740K
|
Health Technology
|
| O: -2.31%
H: 2.33%
C: 1.16%
GOOGL | News S | $156.3 1.43% 1.41% 26M
|
Technology Services
|
| O: 0.14%
H: 2.16%
C: 1.28%
GOOG | News S | $157.96 1.44% 1.42% 15M
|
Technology Services
|
| O: 0.19%
H: 2.04%
C: 1.24%
OCX | News | $2.51 0.4% 0.4% 63K
|
Health Technology
|
| O: 0.8%
H: 1.59%
C: -0.4%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.41%
H: 1.19%
C: 0.41%
VXRT | News | $0.7625 0.91% 0.9% 940K
|
Health Technology
|
| O: 2.63%
H: 2.56%
C: -2.56%
TXMD | News | $1.88 1.08% 1.06% 19K
|
Health Technology
|
| O: 0.54%
H: 3.21%
C: 0.53%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
PTCT | News S | $25.96 2.53% 2.47% 650K
|
Health Technology
|
| O: 0.08%
H: 4.54%
C: 2.49%
NKTR | News | $1.37 10.48% 9.49% 2M
|
Health Technology
|
| O: 5.65%
H: 7.63%
C: 3.82%
MOR | News | $17.97 -0.06% -0.06% 330K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
GLPG | News | $29.09 0.03% -0.14% 80K
|
Health Technology
|
| O: -0.41%
H: 1.52%
C: 0.38%
RLYB | News | $1.79 1.7% 1.68% 270K
|
|
| O: 1.14%
H: 3.37%
C: -0.56%
biopharma
Biopharma Layoff Tracker 2024: Sanofi, Vedanta, Fujifilm and More Cut Staff
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
RLYB | News | $1.79 1.7% 1.68% 270K
|
|
| O: 1.14%
H: 3.37%
C: -0.56%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.41%
H: 1.19%
C: 0.41%
VXRT | News | $0.7625 0.91% 0.9% 940K
|
Health Technology
|
| O: 2.63%
H: 2.56%
C: -2.56%
TXMD | News | $1.88 1.08% 1.06% 19K
|
Health Technology
|
| O: 0.54%
H: 3.21%
C: 0.53%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
PTCT | News S | $25.96 2.53% 2.47% 650K
|
Health Technology
|
| O: 0.08%
H: 4.54%
C: 2.49%
NKTR | News | $1.37 10.48% 9.49% 2M
|
Health Technology
|
| O: 5.65%
H: 7.63%
C: 3.82%
MOR | News | $17.97 -0.06% -0.06% 330K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
GLPG | News | $29.09 0.03% -0.14% 80K
|
Health Technology
|
| O: -0.41%
H: 1.52%
C: 0.38%
AMRN | News | $0.8648 0.64% 0.64% 740K
|
Health Technology
|
| O: -2.31%
H: 2.33%
C: 1.16%
GOOGL | News S | $156.3 1.43% 1.41% 26M
|
Technology Services
|
| O: 0.14%
H: 2.16%
C: 1.28%
GOOG | News S | $157.96 1.44% 1.42% 15M
|
Technology Services
|
| O: 0.19%
H: 2.04%
C: 1.24%
OCX | News | $2.51 0.4% 0.4% 63K
|
Health Technology
|
| O: 0.8%
H: 1.59%
C: -0.4%
biopharma
AbbVie Tops Doctor Ranking of Immunology Companies, Handily Beating Pfizer and J&J
Published: 2024-04-22 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.41%
H: 1.19%
C: 0.41%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
abbvie immunology
23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer
Published: 2024-04-22 (Crawled : 05:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
pharma cancer for
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.